Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 4
2005 2
2006 2
2007 2
2008 3
2009 3
2010 2
2011 6
2012 6
2013 2
2014 7
2015 7
2016 8
2017 4
2018 6
2019 10
2020 10
2021 11
2022 6
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean wenhao wu (184 results)?
TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence.
Wu G, Yoshida N, Liu J, Zhang X, Xiong Y, Heavican-Foral TB, Mandato E, Liu H, Nelson GM, Yang L, Chen R, Donovan KA, Jones MK, Roshal M, Zhang Y, Xu R, Nirmal AJ, Jain S, Leahy C, Jones KL, Stevenson KE, Galasso N, Ganesan N, Chang T, Wu WC, Louissaint A, Debaize L, Yoon H, Dal Cin P, Chan WC, Ho Sui SJ, Ng SY, Feldman AL, Horwitz SM, Adelman K, Fischer ES, Chen CW, Weinstock DM, Brown M. Wu G, et al. Sci Transl Med. 2023 Sep 20;15(714):eadi7244. doi: 10.1126/scitranslmed.adi7244. Epub 2023 Sep 20. Sci Transl Med. 2023. PMID: 37729434 Free PMC article.
Mitofusin-2: A New Mediator of Pathological Cell Proliferation.
Xin Y, Li J, Wu W, Liu X. Xin Y, et al. Among authors: wu w. Front Cell Dev Biol. 2021 Apr 1;9:647631. doi: 10.3389/fcell.2021.647631. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33869201 Free PMC article. Review.
Glycocalyx Impairment in Vascular Disease: Focus on Inflammation.
Qu J, Cheng Y, Wu W, Yuan L, Liu X. Qu J, et al. Among authors: wu w. Front Cell Dev Biol. 2021 Sep 13;9:730621. doi: 10.3389/fcell.2021.730621. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34589494 Free PMC article. Review.
Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1.
Wu W, Nelson GM, Koch R, Donovan KA, Nowak RP, Heavican-Foral TB, Nirmal AJ, Liu H, Yang L, Duffy J, Powers F, Stevenson KE, Jones MK, Ng SY, Wu G, Jain S, Xu R, Amaka S, Trevisani C, Donaldson NL, Hagner PR, de Leval L, Gaulard P, Iqbal J, Thakurta A, Fischer ES, Adelman K, Weinstock DM. Wu W, et al. Blood. 2022 Mar 31;139(13):2024-2037. doi: 10.1182/blood.2021014701. Blood. 2022. PMID: 34936696 Free PMC article.
[Overexpression of miR-130a-3p attenuates cardiomyocyte hypertrophy].
Wang X, Qu J, Li D, Li J, Wu W, Liu X. Wang X, et al. Among authors: wu w. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2020 Apr 25;37(2):340-348. doi: 10.7507/1001-5515.201911049. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2020. PMID: 32329288 Free PMC article. Chinese.
Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas.
Koch R, Christie AL, Crombie JL, Palmer AC, Plana D, Shigemori K, Morrow SN, Van Scoyk A, Wu W, Brem EA, Secrist JP, Drew L, Schuller AG, Cidado J, Letai A, Weinstock DM. Koch R, et al. Among authors: wu w. Blood. 2019 Feb 7;133(6):566-575. doi: 10.1182/blood-2018-07-865527. Epub 2018 Nov 29. Blood. 2019. PMID: 30498064 Free PMC article.
108 results